Why is "semaglutide sodium" a red flag on a compounded label?

The pharmacy is accredited and I have verified that on the accreditor register.

I have read the primary source rather than the summary, which has left me with more questions.

I understand the headline. I do not understand the footnotes, and the footnotes look important.

What would I need in addition before this supported a decision?

The short version: legitimate under a prescription within defined limits, unapproved by definition, and quality depends entirely on the facility.

A compounded preparation has no marketing authorisation, no batch release by a qualified person and no pharmacovigilance obligation attached to it. That is the structural difference from a licensed product.

Additives are the other divergence. Preparations combining an active with vitamins or other agents are not equivalent to the approved product and have not been studied in that combination.

Beyond-use dating for compounded sterile preparations is governed by published standards keyed to the compounding environment.

The framework is jurisdiction-specific. Check yours rather than a general answer.

The honest answer is that a well-run compounding pharmacy is a serious operation and that the variance across facilities is wide.

Beyond-use dates on compounded sterile preparations are set by standards that depend on the preparation environment and are much shorter than a manufactured product's shelf life.

Compounding is the preparation of a medicine for an individual patient in response to a prescription, where an approved product is unsuitable. It sits outside the approval framework by design rather than by omission.

Nothing here is medical advice.

Check the beyond-use date and what it was based on.

edited 4 Oct 2024 by kwn_analytical — removed a claim I could not source

The underlying point is that the relevant distinction is between compounding for an individual patient and compounding at scale, which are regulated differently.

Ask for the certificate of analysis on the compounded lot. A serious facility will have one; the request itself is informative.

Prohibitions on compounding essential copies of commercially available products are explicit in the relevant regulatory frameworks, with shortage listings as the usual exception.

Facility quality is the dominant variable and cannot be assessed from a website.

Ask for the certificate of analysis on the lot. A serious facility has one.

edited 5 Sept 2024 by ilaria_bertone — updated for the 2026 guidance change

This is an area where the legal position and the quality question are separate and both matter.

Regulators generally prohibit compounding what is essentially a copy of a commercially available product, with a shortage listing being the usual exception that permits it temporarily.

The caveat is that the legal and regulatory position differs by jurisdiction and nothing here is legal advice.

Compounded means unapproved by definition. That is structural, not pejorative.